Novo Nordisk Haemophilia Foundation (NNHF)
Together delivering life-changing action
With proper diagnosis and care haemophilia and allied bleeding disorders are treatable. People can lead normal lives and have a near-normal life expectancy. This is however not the situation everywhere, particularly in the developing world, where 75% of the global patient population lives, many patients remain undiagnosed or do not receive adequate treatment.
Improving access to care
Together with local partners, the NNHF is dedicated to define and fund sustainable programmes which improve access to care benefitting people with haemophilia and allied bleeding disorders in the developing world.
In collaboration with internationally renowned experts, the NNHF addresses three focus areas which guide every initiative; capacity building, diagnosis and registry as well as disease education and raising awareness.
NNHF development programmes
Learn more about the NNHF programmes
The NNHF currently funds three types of development programmes: development projects tailored to local needs, fellowships and awards. To date, the NNHF supports programmes in 49 countries across the world.